Nasal challenges with recombinant derivatives of the major birch pollen allergen Bet v 1 induce fewer symptoms and lower mediator release than rBet v 1 wild-type in patients with allergic rhinitis
2002 ◽
Vol 32
(10)
◽
pp. 1448-1453
◽
Keyword(s):
Bet V 1
◽
2009 ◽
Vol 124
(1)
◽
pp. 135-142.e21
◽